Cancer vaccine packaged in minute particles

February 23, 2016
Cancer vaccine packaged in minute particles

Leiden researchers have carried out successful tests using a new method of packaging a cancer vaccine in nanoparticles. The new vaccine has induced a strong immune reaction in mice. The researchers believe that this method can make an important contribution to the treatment of cancer. Their findings have been published in the Journal of Controlled Release.

Vaccination is a promising new treatment method for cancer patients. The method makes use of the way cancer develops, starting from minor errors in DNA. The body is able to recognise these mutations and respond to them with an . Vaccines have the same goal: to cause an immune reaction in the body so that it can recognise and dispose of cancer cells.

Not a matter of a simple injection

Researchers Ana Luisa Silva and Eleni Maria Varypataki from Leiden University and the LUMC are working on such vaccines. In particular, they are studying how , derived from proteins that are characteristic for cancer cells, can be made into a vaccine. Synthetic long peptides do not work as vaccines if they are simply injected, because of the do not absorb them sufficiently to induce an immune reaction.


This is why the researchers use tricks to smuggle the tumour peptides into the antigen-presenting cells of the immune system. To date, many tests have been done with peptides enclosed in water droplets that are combined with oil to form an emulsion. The system does, however, have some disadvantages: the body cannot decompose the components and they are not wholly effective.'


The Leiden researchers are therefore focusing their attention on another, improved system: nanoparticles. The peptides are packaged in nanoparticles together with an adjuvant. The adjuvant stimulates the immune system to work even more effectively. The researchers tested two different particles: so-called PLGA particles and liposomes, artificial vesicles. The researchers knew from previous studies that these small particles are readily absorbed by antigen-presenting cells.


In trials with mice they compared the performance of peptides in the two nano-particles with conventional vaccines. In particular the liposomes seemed to cause a stronger immune reaction in the mice: they produced more T-cells, cells that are involved in destroying in the body. 'Given their performance and their anticipated better safety profile, the newly discovered nano-particles could be a promising transport system for immunotherapy to fight cancer,' Varypataki concluded.

Tumour growth inhibited

In an as yet unpublished follow-up study, the researchers discovered that the introduced into the body via nano-particles clearly inhibited the growth of two different types of tumours. Varypataki: 'This finding again underlines the potential of using liposomes loaded with peptides as a candidate for vaccines.'


The Leiden researchers will be testing other peptides for their suitability as cancer vaccines. Varypataki hopes that, 'combined with other therapies, this could lead to treatments to combat melanonas, and colon and lung cancer.' The clinical development of the method has yet to start so there is still a long way to go before patients can be treated with liposomes combined with .

Explore further: Scientists identify factor that may trigger type 1 diabetes

Related Stories

Scientists identify factor that may trigger type 1 diabetes

February 11, 2016

A team of researchers, led by investigators at the University of Colorado School of Medicine, have identified a new class of antigens that may be a contributing factor to type 1 diabetes, according to an article published ...

'Stealth' nanoparticles could improve cancer vaccines

October 1, 2014

Cancer vaccines have recently emerged as a promising approach for killing tumor cells before they spread. But so far, most clinical candidates haven't worked that well. Now, scientists have developed a new way to deliver ...

One cell type may quash tumor vaccines

April 28, 2014

Most cancer vaccines have not lived up to their promise in clinical trials. The reason, many researchers suspect, is that the immune cells that would help the body destroy the tumor – even those reactions boosted by cancer ...

Hepatitis virus-like particles as potential cancer treatment

February 3, 2016

UC Davis researchers have developed a way to use the empty shell of a Hepatitis E virus to carry vaccines or drugs into the body. The technique has been tested in rodents as a way to target breast cancer, and is available ...

Flu infection reveals many paths to immune response

September 28, 2015

A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological ...

Recommended for you

A 100-fold leap to GigaDalton DNA nanotech

December 6, 2017

DNA, present in almost every cell, is increasingly being used as a building material to construct tiny, but sophisticated structures such as autonomous 'DNA walkers' that can move along a microparticle surface, fluorescent ...

Go with the flow (or against it)

December 6, 2017

Queen's University researchers are using magnetic fields to influence a specific type of bacteria to swim against strong currents, opening up the potential of using the microscopic organisms for drug delivery in environments ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.